Loading clinical trials...
Loading clinical trials...
A Multicenter, Placebo Controlled, Randomized, Double Blind, Subject Initiated Study of the Safety and Efficacy of a Single Topical Iontophoretic Application of Acyclovir 5% Cream With an Open Label Conventional Therapy Treatment Arm, and a Blinded Evaluator, for the Treatment of Recurrent Herpes Labialis
Conditions
Interventions
iontophoretic acyclovir
Locations
26
United States
Radiant Research Birmingham
Birmingham, Alabama, United States
Radiant Research Phoenix Southeast
Chandler, Arizona, United States
Radiant Research Phoenix
Phoenix, Arizona, United States
Radiant Research Scottsdale
Scottsdale, Arizona, United States
Radiant Research San Diego
San Diego, California, United States
Radiant Research Santa Rosa
Santa Rosa, California, United States
Start Date
April 1, 2005
Completion Date
December 1, 2005
Last Updated
July 4, 2006
NCT02965781
NCT03977792
NCT00306293
NCT03310294
NCT03307772
NCT02207881
Lead Sponsor
Transport Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions